Here are the world's Top 10 pharma companies by sales volume in 2020 (since sales is what we need a partner for):
1. Johnson & Johnson – $56.1bn
2. Pfizer – $51.75bn
3. Roche – $49.23bn
4. Novartis – $47.45bn
5. Merck & Co. – $46.84bn
6. GlaxoSmithKline – $44.27bn
7. Sanofi – $40.46bn
8. AbbVie – $33.26bn
9. Takeda – $30.52bn
10. Shanghai Pharmaceuticals Holding – $26.69bn
We might have different partners for different regions, of course, but for the US especially (our largest addressable geography) i'd prefer one of the true big boys. Whichever one comes through with the best offer.
Joint Venture, page-11
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
20.5¢ |
Change
-0.005(2.38%) |
Mkt cap ! $71.73M | |||
| Open | High | Low | Value | Volume |
| 20.0¢ | 21.0¢ | 20.0¢ | $152.8K | 744.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 78174 | 20.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 21.0¢ | 84426 | 5 |
View Market Depth
| Last trade - 16.10pm 01/11/2024 (20 minute delay) ? |
| PAR (ASX) Chart |